VIR logo

Vir Biotechnology (VIR) Long Term Liabilities

Annual Total Long Term Liabilities

$153.42 M
-$59.68 M-28.01%

December 31, 2023


Summary


Performance

VIR Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIRbalance sheetmetrics:

Quarterly Long Term Liabilities

$140.47 M
+$995.00 K+0.71%

September 30, 2024


Summary


Performance

VIR Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIRbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

VIR Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.0%+0.7%
3 y3 years+49.2%-33.1%
5 y5 years-53.6%-33.1%

VIR Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-28.0%at low-41.0%+0.7%
5 y5-year-28.0%+430.4%-41.0%+385.7%
alltimeall time-53.6%+430.4%-78.7%+857.1%

Vir Biotechnology Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$140.47 M(+0.7%)
Jun 2024
-
$139.47 M(-8.6%)
Mar 2024
-
$152.54 M(-0.6%)
Dec 2023
$153.42 M(-28.0%)
$153.42 M(-25.1%)
Sep 2023
-
$204.76 M(-1.6%)
Jun 2023
-
$208.04 M(-0.9%)
Mar 2023
-
$209.85 M(-1.5%)
Dec 2022
$213.10 M(+17.6%)
$213.10 M(-10.4%)
Sep 2022
-
$237.91 M(+25.8%)
Jun 2022
-
$189.11 M(+2.9%)
Mar 2022
-
$183.75 M(+1.4%)
Dec 2021
$181.18 M
$181.18 M(+80.8%)
DateAnnualQuarterly
Sep 2021
-
$100.22 M(-42.5%)
Jun 2021
-
$174.23 M(+41.0%)
Mar 2021
-
$123.53 M(+20.1%)
Dec 2020
$102.84 M(+255.6%)
$102.84 M(+90.8%)
Sep 2020
-
$53.91 M(+0.7%)
Jun 2020
-
$53.52 M(+32.5%)
Mar 2020
-
$40.38 M(+39.6%)
Dec 2019
$28.92 M(-91.3%)
$28.92 M(-95.6%)
Sep 2019
-
$659.12 M(+4391.2%)
Jun 2019
-
$14.68 M(-95.6%)
Dec 2018
$330.87 M(+7.4%)
$330.87 M
Dec 2017
$308.04 M
-

FAQ

  • What is Vir Biotechnology annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Vir Biotechnology?
  • What is Vir Biotechnology annual total long term liabilities year-on-year change?
  • What is Vir Biotechnology quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Vir Biotechnology?
  • What is Vir Biotechnology quarterly long term liabilities year-on-year change?

What is Vir Biotechnology annual total long term liabilities?

The current annual total long term liabilities of VIR is $153.42 M

What is the all time high annual total long term liabilities for Vir Biotechnology?

Vir Biotechnology all-time high annual total long term liabilities is $330.87 M

What is Vir Biotechnology annual total long term liabilities year-on-year change?

Over the past year, VIR annual total long term liabilities has changed by -$59.68 M (-28.01%)

What is Vir Biotechnology quarterly total long term liabilities?

The current quarterly long term liabilities of VIR is $140.47 M

What is the all time high quarterly long term liabilities for Vir Biotechnology?

Vir Biotechnology all-time high quarterly total long term liabilities is $659.12 M

What is Vir Biotechnology quarterly long term liabilities year-on-year change?

Over the past year, VIR quarterly total long term liabilities has changed by +$995.00 K (+0.71%)